Related Experiment Video
Updated: May 17, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid saturation modulates the interaction of anastrozole with biointerfaces
Guilherme Veronezi1, Matheus E Rosa1, Jefferson Carnevalle Rodrigues1
1Departamento de Química, Universidade Federal de São Paulo, Diadema, SP, Brazil.
None:
The interaction of anastrozole, an anticancer drug, with lipid biointerfaces was investigated using Langmuir monolayers of DPPS (saturated lipid) and POPS (unsaturated lipid) to model different membrane environments. Surface pressure-area isotherms revealed that anastrozole induced a slight condensation in DPPS monolayers, while significantly condensing POPS at higher surface pressures, indicating attractive interactions with the unsaturated lipid. The surface dilatational modulus remained largely unaffected for DPPS but decreased for POPS, highlighting a reduction in the surface elasticity. Brewster Angle Microscopy (BAM) images showed the formation of domains in anastrozole-POPS monolayers, whereas DPPS monolayers retained a homogeneous morphology. Infrared spectroscopy indicated that anastrozole increased the conformational order of DPPS alkyl chains while decreasing order in POPS, further supporting the lipid-specific effects of the drug. These findings suggest that lipid saturation plays a critical role in modulating drug-lipid interactions, with anastrozole exhibiting a higher affinity for unsaturated lipids, potentially influencing its bioavailability and mechanism of action at biomembrane interfaces. The results provide insights into the physicochemical behavior of anastrozole in lipid-rich environments, which may be relevant for drug delivery and therapeutic applications.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
09:26Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
Related Concept Videos
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drug Distribution: Tissue Binding
For...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Drug Biotransformation: Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents